Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? The net payment made by Sino to acquire LaNova will be approximately $500.9m, a figure that excludes the estimated cash and bank deposits, according to a company document outlining the terms of the transaction.

Packaging

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? By GlobalData Learn more about Strategic Intelligence Blenrep was approved under the FDA accelerated approval process in 2020 to treat multiple myeloma (MM). Stay proactive with real-time data and expert analysis.

Communication

Beckers Hospital Review

AUGUST 8, 2025

Dr. Arline leads patient safety, quality, analytics, documentation and infection control at BayCare Health System, a 16-hospital network. Under his guidance, Penn Medicine continues to achieve national recognition for its pioneering research, including CAR T cell therapy and Nobel Prize-winning mRNA vaccine technology.

Hospitals

Beckers Hospital Review

JULY 11, 2025

Cass Health completed a $20 million remodel using operating revenue, without incurring debt, between 2020 and 2023. Hoey directed field hospital operations and oversaw a mass vaccination program that administered over 140,000 doses. In 2020, the Utah Department of Health named Mr. Packer CEO of the year. During the pandemic, Ms.

Hospitals

pharmaphorum

MARCH 16, 2021

European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. As it conducted its analysis of the vaccine in December, the European Medicines Agency’s systems were targeted by unknown hackers.

Vaccines

pharmaphorum

DECEMBER 10, 2020

The US government’s coronavirus vaccine chief has said that Pfizer/BioNTech’s vaccine could carry a warning that it should be avoided by people who are prone to serious allergic reactions. Both recovered after appropriate treatment. Both are recovering well.”.

Vaccines

pharmaphorum

NOVEMBER 20, 2020

Pfizer and BioNTech have filed for emergency use of their COVID-19 vaccine candidate in the US, paving the way for a launch before year-end. On the efficacy side, the filing will highlight a vaccine efficacy rate of 95% in a phase 3 study testing patients with and without previous infection with SARS-CoV-2.

Vaccines

Pharmaceutical Technology

SEPTEMBER 15, 2022

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccines

pharmaphorum

JANUARY 13, 2021

Hackers posted stolen confidential information about Pfizer/BioNTech’s COVID-19 vaccine online, the European Medicines Agency has said in an update. The EMA last month revealed that documents relating to the Pfizer/BioNTech vaccine were stolen in a cyber-attack on its records.

Vaccines

Eye on FDA

NOVEMBER 17, 2020

Coincident to COVID-19 case levels in Europe and the United States entering new and serious levels comes welcome news on the development of a vaccine. While vaccination may actually begin in December, the number of doses will be limited. In addition, the process of vaccination takes time.

Communication

Pharmaceutical Technology

DECEMBER 13, 2022

In 2020, the pharmaceutical supply chain faced one of its biggest global challenges. To develop a vaccine and then get as many people vaccinated as quickly as possible. Advanced monitoring and analysis technology has enabled more than 13 billion COVID-19 vaccinations to be distributed worldwide to date.

Vaccines

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines

Beckers Hospital Review

JULY 25, 2025

Mr. Awan spearheaded the deployment of an ambient AI solution that reduced clinician documentation time by 25%, directly improving provider satisfaction and patient experience. Mr. Colarusso led the system’s efforts to standardize its EHR platform, completed in 2020, and has overseen multiple acquisitions and onboarding of new hospitals.

Hospitals

pharmaphorum

APRIL 16, 2021

IQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity for companies to focus on and address in 2021. It is undeniable that 2020 was a particularly challenging year to launch non-COVID innovative prescription medicines.

Pharmaceutical Companies

pharmaphorum

MAY 16, 2022

In 2020, USAID launched two policy documents to guide how the agency invests in digital infrastructure as part of its development and humanitarian assistance programmes: Digital Strategy and Vision for Action in Digital Health (aka Digital Health Vision).

Documentation

Putting Patients First Blog

APRIL 30, 2024

Key Points of Support Conciseness and Focus of Key Information The NHC supports the FDA’s emphasis on beginning the informed consent document with concise, focused presentations of key information. The importance of using plain language in health communications is well-documented in literature.

Documentation

STAT

JULY 1, 2025

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the development of the company’s Covid-19 vaccine was purposefully delayed until after the 2020 presidential election , CNN reports.

Vaccines

Express Pharma

SEPTEMBER 18, 2023

Our virtual twins have been used to swiftly develop COVID-19 vaccines, optimise surgical procedures, and provide patients with a greater understanding of treatment options. Emma Twin is the next act in Dassault Systèmes’ “The Only Progress is Human” initiative, dedicated to healthcare and patient experience.

Documentation

Drug Channels

OCTOBER 13, 2020

I am pleased to announce our new 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Drug Distribution Industry (press release) We’re offering special discounted pricing if you order before October 23, 2020! Copyright © 2006-2020 Pembroke Consulting, Inc.

Pharmaceutical Manufacturing

Pharma in Brief

OCTOBER 25, 2020

They supersede all previous guidance documents, policy communiqués and written or verbal statements of any kind by the PMPRB regarding the administration of the price review process and investigations, including all previous versions of the PMPRB’s Compendium of Guidelines, Policies and Procedures. Changes to the Guidelines.

Documentation

pharmaphorum

OCTOBER 28, 2020

A 2020 survey from DrugsDisclosed.com of 3,346 users of prescription and over the counter (OTC) medicines from the UK and the Nordics revealed that: more than three-quarters of patients do not trust advice from pharmaceutical companies about their medication; 81% feel the pharmaceutical industry influences prescription decisions; and.

Vaccines

Pharma in Brief

JANUARY 9, 2022

In response to the COVID-19 pandemic, in 2020, the Minister of Health signed interim orders designed to streamline the process to authorize the importation or sale of drugs, vaccines, and medical devices used to diagnose, treat, mitigate, or prevent COVID-19. The FCA also provided guidance on “inventive concept”.

Documentation

pharmaphorum

JANUARY 18, 2022

million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Understand requirements to facilitate the documentation preparation needed to obtain a NB Opinion. Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. 13.00 – 17.00.

Packaging

pharmaphorum

SEPTEMBER 14, 2022

With countless media stories regarding COVID-19 published over a period of several years, it was obvious that people around the globe were tuned in to every step of the fight against the pandemic, eagerly learning about everything from symptoms to vaccine development. based site management organization.

Vaccines

European Pharmaceutical Review

JANUARY 16, 2023

He warned, “Implementation of a CCS will require more than writing documents.”. The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.” Perhaps we will see a universal flu vaccine in the near future. References.

Vaccines

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. For pharma, the impact in critical areas such as the performance of newly marketed innovation has already been documented.

Vaccines

Putting Patients First Blog

JULY 22, 2024

This includes wholesalers, payers, and other entities involved in pricing and distribution, all of which significantly influence the availability and cost of medical products, including drugs, biologics, vaccines, and devices. Although these considerations extend beyond the current RFI, the NHC believes they warrant attention. 2024, June 11).

Documentation

PharmaTech

JUNE 23, 2025

It builds on drug calculations topics previously described (1), including guidance documents (2–5). FDA guidance documents illustrate labeling salt drugs and associated active moieties. Discussion topics Part two of this series ( click here for part one ) addresses numeric calculations for types of bulk drugs. Phenytoin Dosage.

Compounding

European Pharmaceutical Review

NOVEMBER 9, 2022

Within recent years this situation has been further exacerbated by the COVID-19 pandemic: both directly, through viral vaccine manufacture; and indirectly, through instability in global supply chains. An analysis performed at the end of 2019 concluded that demand for viral vectors would have surpassed CDMO capacity during 2020.

Vaccines

pharmaphorum

DECEMBER 16, 2020

Moderna looks odds on to claim emergency use authorisation from the FDA for its COVID-19 vaccine this week, after the regulator published a report endorsing its safety and rating its efficacy at 94.5%. — Eric Topol (@EricTopol) December 15, 2020. Both vaccines will be provided free of charge to recipients.

Vaccines

STAT

OCTOBER 16, 2024

But the underlying message to doctors in late 2020 was persistent and urgent: Hit your targets to see more patients. At the time, deaths from Covid-19 were surging, and no vaccine was available. We need to bring in more money. One email trumpeted “ADDITIONAL BONUSES!!

Documentation

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022.

Vaccines

Pharmaceutical Technology

NOVEMBER 15, 2022

Within Pfizer’s Covid-19 pipeline, Pfizer and BioNtech’s vaccine Comirnaty is also being used to fight the pandemic. While bivalent formulations of Comirnaty and Moderna’s Spikevax vaccine have both been authorised for use as boosters in the UK and US, their uptake has remained slow. 7)) and the other one in common between the BA.4

Vaccines

Pharma in Brief

SEPTEMBER 22, 2020

On September 16, 2020, the Minister of Health signed an Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 (the Interim Order ) which provides new regulatory pathways to expedite the approval of COVID-19 drugs and vaccines that have not yet been approved for sale in Canada.

Vaccines

pharmaphorum

DECEMBER 19, 2022

So, it was that Poland had to provide the necessary cancer care and, indeed, soon after the war started, it had been decided that refugees would have the same care as Polish patients – despite the difficulties faced by having no Polish documentation. Industry’s learning from the pandemic.

Documentation

pharmaphorum

OCTOBER 18, 2021

The development of COVID-19 vaccines required levels of cooperation and pioneering science comparable to the Apollo space programme. Within 12 months of the outbreak, vaccines were being deployed to prevent severe infections, hospitalisation, and death. billion people have been fully vaccinated. COVID-19 vaccine tracker.

Vaccines

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . We published our hypothesis in the Lancet on February 4 in 2020.

Drug Development